🟢 Firefly Neuroscience is trading 6.54% up in pre-market despite no clear company-specific catalyst

Firefly Neuroscience is trading at $1.14 (+6.54%) with no credible company-specific catalyst identified in overnight coverage.

• No credible September 14, 2026 company-specific announcement, earnings release, or filing was identified; the latest surfaced quarterly filing was submitted August 11, 2026.
• Firefly Neuroscience is rising despite weaker pre-market indices, so broad market sentiment does not explain the move. Its July partnership and August clinical-assessment growth announcement appear stale rather than direct catalysts.